Live News Categoriesmarket

VVOS.US.EQUI (VVOS.US.EQUI) News

Follow VVOS.US.EQUI (VVOS.US.EQUI) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 1 public stories across 1 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.

Symbol VVOS.US.EQUI Asset market Sector Markets 90 days 1 Updated Jul 08, 2026, 07:28 PM UTC Open live news feed

H Vivos Therapeutics price target lowered to 75c from $1.75 at Alliance Global Alliance Global lowered the firm's price target on Vivos Therapeutics to 75c from $1.75 and keeps a Neutral rating on the shares after the company reported Q1 earnings on May 20. The balance sheet needs "significant rein EQUITY | Jul 08, 2026, 07:28 PM UTC